Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.99B |
| 2 |
Apple
AAPL
|
+$2.23B |
| 3 |
NVIDIA
NVDA
|
+$1.92B |
| 4 |
Amazon
AMZN
|
+$1.75B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.1B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALTR
Altair Engineering Inc
ALTR
|
+$152M |
| 2 |
Merck
MRK
|
+$142M |
| 3 |
SUM
Summit Materials, Inc. Class A Common Stock
SUM
|
+$141M |
| 4 |
ALTM
Arcadium Lithium plc
ALTM
|
+$132M |
| 5 |
AZPN
Aspen Technology Inc
AZPN
|
+$131M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.36% |
| 2 | Financials | 14.54% |
| 3 | Healthcare | 11.04% |
| 4 | Consumer Discretionary | 10.44% |
| 5 | Communication Services | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Northrim BanCorp
NRIM
$600M
| $9.46M | ﹤0.01% |
516,448
+15,468
| +3% | +$306K |
|
2327
Nice
NICE
$5.82B
| $9.46M | ﹤0.01% |
61,336
-5,805
| -9% | -$929K |
|
2328
Third Coast Bancshares
TCBX
$737M
| $9.44M | ﹤0.01% |
282,700
+8,552
| +3% | +$297K |
|
2329
Marcus Corp
MCS
$949M
| $9.43M | ﹤0.01% |
565,150
+13,976
| +3% | +$270K |
|
2330
Cullinan Oncology
CGEM
$1.08B
| $9.4M | ﹤0.01% |
1,241,817
+27,176
| +2% | +$261K |
|
2331
Dianthus Therapeutics
DNTH
$6.15B
| $9.38M | ﹤0.01% |
517,018
+30,755
| +6% | +$678K |
|
|
SPYM
2332
State Street SPDR Portfolio S&P 500 ETF
SPYM
$167B
| – | – |
0
| – | – |
|
|
CMRC
2333
Commerce.com Inc Series 1
CMRC
$281M
| $9.33M | ﹤0.01% |
1,619,236
+19,709
| +1% | +$125K |
|
|
AVDL
2334
DELISTED
Avadel Pharmaceuticals
AVDL
| $9.31M | ﹤0.01% |
1,189,596
+24,345
| +2% | +$204K |
|
2335
Preformed Line Products
PLPC
$2.3B
| $9.3M | ﹤0.01% |
66,350
+1,646
| +3% | +$224K |
|
|
LENZ
2336
LENZ Therapeutics
LENZ
$165M
| $9.27M | ﹤0.01% |
360,392
+26,366
| +8% | +$649K |
|
2337
AngioDynamics
ANGO
$622M
| $9.27M | ﹤0.01% |
986,720
+12,418
| +1% | +$130K |
|
2338
Zevra Therapeutics
ZVRA
$622M
| $9.24M | ﹤0.01% |
1,233,111
+44,991
| +4% | +$358K |
|
2339
Grindr
GRND
$3.16B
| $9.24M | ﹤0.01% |
515,828
+560
| +0.1% | +$9.83K |
|
2340
Hain Celestial
HAIN
$50.3M
| $9.23M | ﹤0.01% |
2,223,897
-20,102
| -0.9% | -$89.9K |
|
2341
BioNTech
BNTX
$23.3B
| $9.23M | ﹤0.01% |
101,348
-367
| -0.4% | -$41.1K |
|
2342
NetEase
NTES
$82B
| $9.23M | ﹤0.01% |
89,636
-17,670
| -16% | -$1.78M |
|
2343
South Plains Financial
SPFI
$854M
| $9.22M | ﹤0.01% |
278,264
+7,640
| +3% | +$263K |
|
|
EBTC
2344
DELISTED
Enterprise Bancorp
EBTC
| $9.2M | ﹤0.01% |
236,382
+4,366
| +2% | +$179K |
|
2345
Ezcorp Inc
EZPW
$1.83B
| $9.17M | ﹤0.01% |
622,484
+28,632
| +5% | +$378K |
|
2346
AnaptysBio
ANAB
$1.63B
| $9.13M | ﹤0.01% |
491,167
+4,570
| +0.9% | +$76.2K |
|
2347
Treace Medical Concepts
TMCI
$310M
| $9.12M | ﹤0.01% |
1,087,143
+24,378
| +2% | +$219K |
|
2348
Acco Brands
ACCO
$402M
| $9.11M | ﹤0.01% |
2,173,873
+38,183
| +2% | +$187K |
|
2349
Vitamin Cottage Natural Grocers
NGVC
$736M
| $9.09M | ﹤0.01% |
226,037
+8,471
| +4% | +$354K |
|
2350
NovaGold Resources
NG
$3.02B
| $9.09M | ﹤0.01% |
3,110,890
+43,746
| +1% | +$141K |
|
Similar funds
Geode Capital Management's Q1 2025 Portfolio in Review
As of Q1 2025, Geode Capital Management held 4,591 positions worth $1.27T, down 1.4% from $1.29T the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Geode Capital Management deployed $47.9B of net new capital in Q1 2025, opening 121 new positions and adding to 3,781 existing holdings. Its largest new stake was Sandisk: 1,936,245 shares worth $92.2M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Merck, an estimated $142M trimmed.
- Geode Capital Management's largest Q1 2025 buy was Sandisk: 1,936,245 shares worth $92.2M.
- Geode Capital Management added most to Microsoft in Q1 2025, an estimated $2.99B increase.
- Geode Capital Management's biggest Q1 2025 reduction was Merck, cutting an estimated $142M.
- Geode Capital Management fully exited Altair Engineering Inc in Q1 2025, selling an estimated $152M.
- Geode Capital Management's ten largest holdings make up 29% of its $1.27T portfolio in Q1 2025.
- Geode Capital Management opened 121 new positions and closed 115 in Q1 2025.
- Geode Capital Management's portfolio value fell 1.4% quarter-over-quarter to $1.27T.
Based on Geode Capital Management's 13F filing for Q1 2025, filed 13 May 2025.